肺部疾病中的巨细胞极化:从机制到治疗策略
Jia Wang1, Huajie Niu1, Junwei Kang1
1Department of Rehabilitation Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, P.R. China.
Immunological investigations
|April 11, 2025
概括
准巨细胞两极分化,一个关键的免疫细胞过程,为肺部疾病提供了一个有前途的治疗策略. 调节这些免疫细胞可以帮助平衡炎症和修复,改善治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 肺部病理学 肺部病理学
背景情况:
- 巨细胞是恒常性和病原体防御的重要免疫细胞.
- 它们表现出可塑性,分化为M1 (促炎) 或M2 (抗炎) 现型.
- 极化受到信号通路和转录网络的调节.
研究的目的:
- 审查影响巨细胞两极分化的因素.
- 探索巨细胞极化中的信号通路.
- 为了检查巨细胞两极分化在肺部疾病发病过程中的作用.
主要方法:
- 关于巨细胞生物学近期进展的文献综述.
- 信号通路和转录网络的分析.
- 在纤维化,癌症和炎症等肺部疾病中检查巨细胞两极分化.
主要成果:
- 巨细胞的可塑性是免疫反应的核心.
- 显而易见的微环境线索驱动M1/M2极化.
- 失调的两极分化有助于肺病的进展.
结论:
- 向巨细胞两极分化是肺部疾病的潜在治疗策略.
- 调节极化可以平衡炎症和修复.
- 这种方法可以缓解疾病的进展,并提高治疗的疗效.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
271
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
271
COPD: Pathogenesis and Clinical Features
193
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
193
Asthma: Pathogenesis and Management
254
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
254
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
136
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
136


